Pancreatitis News and Research

RSS
Pancreatitis is inflammation of the pancreas. The pancreas is a large gland behind the stomach and close to the duodenum—the first part of the small intestine. The pancreas secretes digestive juices, or enzymes, into the duodenum through a tube called the pancreatic duct. Pancreatic enzymes join with bile—a liquid produced in the liver and stored in the gallbladder—to digest food. The pancreas also releases the hormones insulin and glucagon into the bloodstream. These hormones help the body regulate the glucose it takes from food for energy.

Normally, digestive enzymes secreted by the pancreas do not become active until they reach the small intestine. But when the pancreas is inflamed, the enzymes inside it attack and damage the tissues that produce them.

Pancreatitis can be acute or chronic. Either form is serious and can lead to complications. In severe cases, bleeding, infection, and permanent tissue damage may occur.
New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

New pragmatic study launched to understand the effectiveness of new type 2 diabetes drug

Researchers identify sex-specific genetic risk factor for pancreatic cancer

Researchers identify sex-specific genetic risk factor for pancreatic cancer

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Phase 3 ECHELON-2 clinical trial evaluating ADCETRIS plus CHP meets primary endpoint

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

Brigatinib drug may offer first-line treatment option for ALK-positive NSCLC

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma

New minimally invasive therapy shows promise for long-term reversal of Type 1 diabetes

New minimally invasive therapy shows promise for long-term reversal of Type 1 diabetes

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

Novartis' new drug combination receives positive CHMP opinion for treating stage III BRAF mutant melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications

Health burdens of very high risk drinking are potentially large, study reveals

Health burdens of very high risk drinking are potentially large, study reveals

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Opdivo plus low-dose Yervoy shows promising results in treating renal cell carcinoma patients

Familial Chylomicronemia Syndrome: How HCP’s can Support Patients with Rare Diseases

Familial Chylomicronemia Syndrome: How HCP’s can Support Patients with Rare Diseases

Gene therapy offers potential cure for patients with lipoprotein lipase deficiency

Gene therapy offers potential cure for patients with lipoprotein lipase deficiency

Pancreatitis risk in minorities linked to alcohol, gallstones and high triglycerides

Pancreatitis risk in minorities linked to alcohol, gallstones and high triglycerides

Clinical study to find improved treatment for visceral leishmaniasis starts in eastern Africa

Clinical study to find improved treatment for visceral leishmaniasis starts in eastern Africa

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

New review explores potentially safer therapies for treating chronic abdominal pain

New review explores potentially safer therapies for treating chronic abdominal pain

Researchers aim to to better predict future chronic opioid therapy in hospital patients

Researchers aim to to better predict future chronic opioid therapy in hospital patients